晨光生物: management transactions · France · AMF SZSE:300138 FR FR · AMF Mcap 6.0Bn€
Browse the full insider trade history of 晨光生物, a listed equity based in France. Shares are listed on FR FR, under the authority of AMF. Market capitalisation: €6bn. The latest transaction was filed on 7 August 2023 — Sale. Among the most active insiders: 李月斋. Every trade is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 6.56 Bn€
Gross profit 859.3 M€ 13% margin
Net income 368.9 M€ 5.6% margin
Balance sheet & cash
Market cap 6.00 Bn€
Total debt 5.12 Bn€
Free Cash Flow 77.7 M€
Last declaration on 7 August 2023
Declarations 12 total
Executives ● Sale7 SZSE
2,700 shares
SZSE:173000006823438980 · 7 Aug 2023
Executives ● Sale7 SZSE
1,100,000 shares
SZSE:173000006282518100 · 15 Feb 2023
Executives ● Sale7 SZSE
1,250,000 shares
SZSE:173000006277878880 · 14 Feb 2023
Executives ● Sale11 SZSE
1,148,000 shares
SZSE:173000006253101660 · 2 Feb 2023
Executives ● Sale11 SZSE
43,800 shares
SZSE:173000005883272220 · 13 Sept 2022
Executives ● Sale11 SZSE
104,700 shares
SZSE:173000005881137470 · 9 Sept 2022
Executives ● Sale7 SZSE
848,900 shares
SZSE:173000005711049760 · 21 Jul 2022
Executives ● Sale7 SZSE
1,508,600 shares
SZSE:173000005700602460 · 20 Jul 2022
Executives ● Sale7 SZSE
12,600 shares
SZSE:173000005218934980 · 12 Jan 2022
Executives ● Sale22 SZSE
1,519,900 shares
SZSE:173000005208274370 · 5 Jan 2022
Executives ● Sale22 SZSE
130,000 shares
SZSE:173000005170251360 · 10 Dec 2021
Executives ● Sale11 SZSE
5,000 shares
SZSE:173000005098858100 · 22 Nov 2021